Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2024

What’s new on antibody-drug conjugates?

Optimising the safety of novel antibody-drug conjugates

Date

28 Feb 2024

Session

What’s new on antibody-drug conjugates?

Topics

Cytotoxic Therapy;  Targeted Therapy;  Immunotherapy

Tumour Site

Presenters

Toshio Shimizu

Authors

T. Shimizu

Author affiliations

  • Pulmonary Medicine And Medical Oncology Dept., Wakayama Medical University, 641-8509 - Wakayama/JP

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.